Status:
WITHDRAWN
Treatment of Chorioamnionitis After Delivery
Lead Sponsor:
United States Naval Medical Center, Portsmouth
Conditions:
Chorioamnionitis
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Chorioamnionitis occurs in 1% to 5% of term pregnancies and may complicate up to 25% of cases of preterm labor. The traditional regimen used to treat intra-amniotic infection is intravenous ampicillin...
Detailed Description
Chorioamnionitis refers to infection of the amniotic fluid, membranes, placenta and/or uterus. Clinical chorioamnionitis is defined by a temperature of 380 C or more and one or more of the following f...
Eligibility Criteria
Inclusion
- .
- All patients that develop chorioamnionitis and who are over 18 years of age will be offered participation in the study.
Exclusion
- Women who do not wish to participate, patients who are allergic to the study antibiotics
- Women who are immunocompromised or women receiving antibiotics for other reasons such as prophylaxis for bacterial endocarditis
Key Trial Info
Start Date :
November 18 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00814905
Start Date
November 18 2008
End Date
September 1 2012
Last Update
August 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Naval Medical Center - Portsmouth
Portsmouth, Virginia, United States, 23708-2197